A life sciences and clinical diagnostics company has raised eyebrows in recent days after an event-driven analyst pointed out that ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE